Medicalgorithmics Q3 2026 revenue up 52% YoY, positive EBITDA

Medicalgorithmics Capital Group reported Q3 2026 revenue of 10.9 million zł, a 52% increase year-over-year, and achieved positive EBITDA. The figures are preliminary estimates, and the company's profitability turnaround marks a notable improvement from prior periods. This is a company-specific earnings update with limited macro impact.